Form 8-K - Current report:
SEC Accession No. 0001104659-21-024288
Filing Date
2021-02-16
Accepted
2021-02-16 16:50:06
Documents
3
Period of Report
2021-02-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216958d1_8k.htm 8-K 17174
2 EXHIBIT 99.1 tm216958d1_ex99-1.htm EX-99.1 65465
3 GRAPHIC image_001.jpg GRAPHIC 4068
  Complete submission text file 0001104659-21-024288.txt   89599
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 21640057
SIC: 2836 Biological Products, (No Diagnostic Substances)